EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Tint: Active Ingredient Strategies for Post‐Inflammatory Hyperpigmentation due to Visible Light in Skin of Color

Willem Izak Visser iD, Husna Moola iD, Susanna Kannenberg iD, Bianca Tod iD, Henry W Lim iD

Photodermatology, Photoimmunology & Photomedicine · 2026-07 · 42 (4)

DOI: 10.1111/phpp.70112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 25.07.2026. Verfasst von Willem Izak Visser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Hauptthemen laut MEDLINE: Hyperpigmentation, Light, Skin Pigmentation, Sunscreening Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐inflammatory hyperpigmentation (PIH) is among the most burdensome sequelae of inflammatory dermatoses in skin of color (SOC), and reduction of visible pigmentation represents the primary clinical outcome of interest. Tinted sunscreens containing iron oxides and/or pigmentary titanium dioxide are currently the best‐evidenced strategy for preventing visible light–driven PIH in SOC. However, cosmetic unacceptability—including white cast, poor shade match, and texture incompatibility with acne‐prone skin—significantly limits real‐world adherence. This concept paper proposes a clinical reframing: when pigment‐based visible light filters are not tolerated, pigmentation reduction may be achievable through proactive topical actives with direct anti‐pigmentation activity.

Methods

This commentary synthesizes the mechanistic and clinical literature on high‐energy visible light (HEVL)–driven pigmentation in SOC, with particular focus on the opsin‐3–MITF–melanogenesis axis and topical actives with demonstrated anti‐pigmentation activity against HEVL‐induced melanogenesis. Evidence is presented to support a proposed clinical reframing and pragmatic algorithm.

Results

HEVL activates opsin‐3 on melanocytes, upregulating MITF and promoting formation of stable, autophagy‐resistant melanosomes—a mechanism distinct from UVA‐driven photooxidation and particularly relevant in darker phototypes. Four prototypical actives with direct clinical or preclinical evidence against HEVL‐induced pigmentation are reviewed.

Conclusion

Pigmentation reduction—rather than the mechanism by which it is achieved—should be recognized as the primary clinical endpoint in photoprotection for PIH in SOC. When pigment‐based visible light filters containing iron oxides and/or pigmentary titanium dioxide are cosmetically unacceptable, a strategy combining broad‐spectrum UVA1 photoprotection with a topical active with anti‐pigmentation activity represents a rational, evidence‐informed alternative that keeps the clinical goal firmly in focus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationLightSkin PigmentationSunscreening AgentsHumansInflammationAnimalsTitanium

Stichwörter der Autor:innen

photoprotectionpost‐inflammatory hyperpigmentationskin of colortinted sunscreenvisible light

Substanzen

Sunscreening AgentsTitaniumtitanium dioxide

Autor:innen und Institutionen

  • Division of Dermatology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Tygerberg Hospital, Cape Town, South Africa.
  • Division of Photobiology and Photomedicine, Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Department of Dermatology, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.

ORCID-Profile: Willem Izak Visser, Husna Moola, Susanna Kannenberg, Bianca Tod, Henry W Lim

Zitieren

APA

Visser, W. I., Moola, H., Kannenberg, S., Tod, B., & Lim, H. W. (2026). Beyond Tint: Active Ingredient Strategies for Post‐Inflammatory Hyperpigmentation due to Visible Light in Skin of Color. Photodermatology, Photoimmunology & Photomedicine, 42(4). https://doi.org/10.1111/phpp.70112

Vancouver

Visser WI, Moola H, Kannenberg S, Tod B, Lim HW. Beyond Tint: Active Ingredient Strategies for Post‐Inflammatory Hyperpigmentation due to Visible Light in Skin of Color. Photodermatology, Photoimmunology & Photomedicine. 2026;42(4). doi:10.1111/phpp.70112

BibTeX
@article{Visser2026,
  author = {Visser, Willem Izak and Moola, Husna and Kannenberg, Susanna and Tod, Bianca and Lim, Henry W},
  title = {Beyond Tint: Active Ingredient Strategies for Post‐Inflammatory Hyperpigmentation due to Visible Light in Skin of Color},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2026},
  volume = {42},
  number = {4},
  doi = {10.1111/phpp.70112}
}
Kostenlos starten →